share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 5 04:55
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月5日向香港聯合交易所有限公司提交了翌日披露報表，披露公司股份購回情況。根據報表，歌禮製藥自2023年12月19日至2024年2月5日期間，透過香港聯交所進行了多次股份購回，合計購回股份達63,621,000股，佔當時已發行股份總數的5.8522%。最後一次購回發生在2024年2月5日，當日購回股份數目為750,000股，每股價格介乎於HKD 1.59至HKD 1.71，總付出金額為HKD 1,212,160。購回後，歌禮製藥的結存已發行股份總數為1,044,821,000股。公司確認，所有購回行動均獲董事會批准，並符合香港聯交所主板上市規則。
歌禮製藥有限公司於2024年2月5日向香港聯合交易所有限公司提交了翌日披露報表，披露公司股份購回情況。根據報表，歌禮製藥自2023年12月19日至2024年2月5日期間，透過香港聯交所進行了多次股份購回，合計購回股份達63,621,000股，佔當時已發行股份總數的5.8522%。最後一次購回發生在2024年2月5日，當日購回股份數目為750,000股，每股價格介乎於HKD 1.59至HKD 1.71，總付出金額為HKD 1,212,160。購回後，歌禮製藥的結存已發行股份總數為1,044,821,000股。公司確認，所有購回行動均獲董事會批准，並符合香港聯交所主板上市規則。
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON FEBRUARY 5, 2024 DISCLOSING THE REPURCHASE OF THE COMPANY'S SHARES. According to the report, between 19 December 2023 and 5 February 2024, Song Pharmaceuticals made multiple share repurchases through the Hong Kong Stock Exchange, totaling 63,621,000 shares, representing 5.8522% of the total number of shares issued at that time. The last repurchase took place on February 5, 2024. The number of shares repurchased on that date was 750,000 shares at a price of HKD 1.59 to HKD 1.71 for a total payment of HKD 1,212,160. Following the repurchase, the total number of shares issued by Kai Pharma is 1,044,821,000 shares. The Company confirms that all repurchases have been approved by the Board of Directors and comply with the Listing Rules of the HKEX Main Board.
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON FEBRUARY 5, 2024 DISCLOSING THE REPURCHASE OF THE COMPANY'S SHARES. According to the report, between 19 December 2023 and 5 February 2024, Song Pharmaceuticals made multiple share repurchases through the Hong Kong Stock Exchange, totaling 63,621,000 shares, representing 5.8522% of the total number of shares issued at that time. The last repurchase took place on February 5, 2024. The number of shares repurchased on that date was 750,000 shares at a price of HKD 1.59 to HKD 1.71 for a total payment of HKD 1,212,160. Following the repurchase, the total number of shares issued by Kai Pharma is 1,044,821,000 shares. The Company confirms that all repurchases have been approved by the Board of Directors and comply with the Listing Rules of the HKEX Main Board.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more